Cargando…

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer

BACKGROUND: Breast cancer is a heterogeneous disease. Compared with other subtypes of breast cancer, triple-negative breast cancer (TNBC) is easy to metastasize and has a short survival time, less choice of treatment options. Here, we aimed to identify the potential biomarkers to TNBC diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Xiuming, Yang, Zhaowei, Liu, Xiji, Dong, Zihe, Zhou, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513746/ https://www.ncbi.nlm.nih.gov/pubmed/33005492 http://dx.doi.org/10.7717/peerj.9975

Ejemplares similares

Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis
por: Lin, Ziyue, et al.
Publicado: (2021)

Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
por: Song, Xiang, et al.
Publicado: (2019)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
por: Liu, Cuiping, et al.
Publicado: (2020)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

FAM83A is a potential biomarker for breast cancer initiation
por: Marino, Natascia, et al.
Publicado: (2022)

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
por: Su, Peng, et al.
Publicado: (2021)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
por: Zhang, Tianhao, et al.
Publicado: (2021)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Immune implication of FAM83D gene in hepatocellular carcinoma
por: Meng, Tao, et al.
Publicado: (2021)

The regulatory effect of 6-TG on lncRNA–miRNA–mRNA ceRNA network in triple-negative breast cancer cell line
por: Zhang, Daoyu, et al.
Publicado: (2021)

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors
por: Suntiparpluacha, Monthira, et al.
Publicado: (2023)

Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment
por: Chen, Bowen, et al.
Publicado: (2020)

Evolutionary analysis of FAM83H in vertebrates
por: Huang, Wushuang, et al.
Publicado: (2017)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
por: Zhang, Kai, et al.
Publicado: (2020)

LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
por: Han, Chunyong, et al.
Publicado: (2020)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
por: Zhu, Zhipeng, et al.
Publicado: (2021)

Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer
por: Xin, Ying, et al.
Publicado: (2020)

FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)

Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker
por: Yu, Haiyang, et al.
Publicado: (2022)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis
por: Xiong, Dan, et al.
Publicado: (2020)

Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer
por: Xu, Wenjie, et al.
Publicado: (2019)

Identification of Biomarkers Controlling Cell Fate In Blood Cell Development
por: Nazarieh, Maryam, et al.
Publicado: (2021)

Identification of biomarkers associated with clinical severity of chronic obstructive pulmonary disease
por: Zhang, Jie, et al.
Publicado: (2020)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

Prognostic significance of FAM83D gene expression across human cancer types
por: Walian, Peter J., et al.
Publicado: (2015)

Cell division cycle proteinising prognostic biomarker of breast cancer
por: Cheng, Lin, et al.
Publicado: (2020)

Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2020)

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
por: OKABE, NAOYUKI, et al.
Publicado: (2015)

The Enamel Phenotype in Homozygous Fam83h Truncation Mice
por: Wang, Shih‐Kai, et al.
Publicado: (2019)

Novel FAM83H mutations in patients with amelogenesis imperfecta
por: Xin, Wang, et al.
Publicado: (2017)

Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease
por: Khurana, Rimpi, et al.
Publicado: (2017)

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
por: Ji, Baowei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lvrr2o0ps2914b0jhca0ad1bdp